Back to Articles
GeneralBusiness Today

How new safety evidence is boosting India’s expanding Ashwagandha market

Government-backed 24-week trial of 1,200 adults finds no liver or kidney injury from a standardised root extract.

Attribution

This digest is published with acknowledgment to Business Today. For the complete analysis, headnotes, and citations, please refer to the source.

Read on Business Today

More Articles